Search Results
Search for other papers by Krystallenia I Alexandraki in
Google Scholar
PubMed
Search for other papers by Gregory A Kaltsas in
Google Scholar
PubMed
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
Search for other papers by Eleftherios Chatzellis in
Google Scholar
PubMed
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
in the range of 2–5 cases/100 000/year ( Yao et al . 2008 , Niederle et al . 2010 , Fraenkel et al . 2012 ). While previous epidemiological data considered appendiceal NENs (aNENs) to be the most common GI-NENs, the overall percentage has
Search for other papers by Nicole Panarelli in
Google Scholar
PubMed
Search for other papers by Kathrin Tyryshkin in
Google Scholar
PubMed
Search for other papers by Justin Jong Mun Wong in
Google Scholar
PubMed
Search for other papers by Adrianna Majewski in
Google Scholar
PubMed
Search for other papers by Xiaojing Yang in
Google Scholar
PubMed
Search for other papers by Theresa Scognamiglio in
Google Scholar
PubMed
Search for other papers by Michelle Kang Kim in
Google Scholar
PubMed
Search for other papers by Kimberly Bogardus in
Google Scholar
PubMed
Search for other papers by Thomas Tuschl in
Google Scholar
PubMed
Search for other papers by Yao-Tseng Chen in
Google Scholar
PubMed
HHMI, Laboratory of RNA Molecular Biology, The Rockefeller University, New York, New York, USA
Search for other papers by Neil Renwick in
Google Scholar
PubMed
ileal and appendiceal NETs (comparison B) and rectal and pancreatic NETs (comparison C). We also compared miRNA expression differences between NETs from each anatomic site of origin (i.e. pancreas, ileum, appendix or rectum) and the remaining three GEP
Search for other papers by Martin B Niederle in
Google Scholar
PubMed
Search for other papers by Monika Hackl in
Google Scholar
PubMed
Search for other papers by Klaus Kaserer in
Google Scholar
PubMed
Search for other papers by Bruno Niederle in
Google Scholar
PubMed
(IQR: 22) and 59 (IQR: 27) years respectively ( P value significant only before correction for multiple testing: P <0.05, then non-significant). Patients with appendiceal NETs were significantly younger (median 38 (IQR: 45) years) than patients with
Search for other papers by R Sutton in
Google Scholar
PubMed
Search for other papers by H E Doran in
Google Scholar
PubMed
Search for other papers by E M I Williams in
Google Scholar
PubMed
Search for other papers by J Vora in
Google Scholar
PubMed
Search for other papers by S Vinjamuri in
Google Scholar
PubMed
Search for other papers by J Evans in
Google Scholar
PubMed
Search for other papers by F Campbell in
Google Scholar
PubMed
Search for other papers by M G T Raraty in
Google Scholar
PubMed
Search for other papers by P Ghaneh in
Google Scholar
PubMed
Search for other papers by M Hartley in
Google Scholar
PubMed
Search for other papers by G J Poston in
Google Scholar
PubMed
Search for other papers by J P Neoptolemos in
Google Scholar
PubMed
Many clinicians prefer to avoid surgery in patients with carcinoid neoplasia, because of its slow growth and relatively favourable prognosis. Nevertheless, the commonest cause of death in patients with carcinoid is advanced metastatic disease, and both clinical and epidemiological data indicate that the more effectively the disease is ablated, the more long-lasting the benefit. Multidisciplinary management of patients with carcinoid must consider inherited risk, possible multiple carcinoids and/or synchronous non-carcinoid cancer, and the use of a range of investigations that also evaluate the 10% of patients with carcinoid syndrome with or without valvular heart disease. Although primary size is correlated with the presence of nodal with or without liver metastases, carcinoid tumours <1 cm in diameter may be metastatic at presentation, particularly those arising within the small intestine. In the jejunum and ileum, resection of all sizes of carcinoid with local and regional nodes is preferred, to prevent nodal dissemination causing mesenteric ischaemia with or without infarction. Resection of nodal metastases should be undertaken in those with persistent or recurrent nodal disease if possible. Appendiceal and right colonic carcinoids are most effectively treated by right hemicolectomy with local and regional nodal clearance, as for adenocarcinoma. However, for most appendiceal carcinoids which are <1 cm in diameter and non-invasive, appendicectomy alone is sufficient. For appendiceal carcinoids 1-2 cm in diameter, histopathological assessment helps to determine the need for hemicolectomy. Liver resection has been followed by prolonged 5 year survival in several series and is recommended in appropriate patients to attempt cure or to debulk metastatic disease. Liver transplantation has had only qualified success in highly selected patients without extra-hepatic disease in whom other therapies have failed.
Search for other papers by Francesco Panzuto in
Google Scholar
PubMed
Search for other papers by Silvia Nasoni in
Google Scholar
PubMed
Search for other papers by Massimo Falconi in
Google Scholar
PubMed
Search for other papers by Vito Domenico Corleto in
Google Scholar
PubMed
Search for other papers by Gabriele Capurso in
Google Scholar
PubMed
Search for other papers by Sara Cassetta in
Google Scholar
PubMed
Search for other papers by Michela Di Fonzo in
Google Scholar
PubMed
Search for other papers by Valentina Tornatore in
Google Scholar
PubMed
Search for other papers by Massimo Milione in
Google Scholar
PubMed
Search for other papers by Stefano Angeletti in
Google Scholar
PubMed
Search for other papers by Maria Sofia Cattaruzza in
Google Scholar
PubMed
Search for other papers by Vincenzo Ziparo in
Google Scholar
PubMed
Search for other papers by Cesare Bordi in
Google Scholar
PubMed
Search for other papers by Paolo Pederzoli in
Google Scholar
PubMed
Search for other papers by Gianfranco Delle Fave in
Google Scholar
PubMed
of patients with appendiceal tumors was excluded from the risk factors analysis; it is well known that these tumors are usually characterized by a low risk of metastases and a relatively benign behavior ( Sutton et al. 2003 ). In fact, even in this
Search for other papers by Yvonne Arvidsson in
Google Scholar
PubMed
Search for other papers by Ellinor Andersson in
Google Scholar
PubMed
Search for other papers by Anders Bergström in
Google Scholar
PubMed
Search for other papers by Mattias K Andersson in
Google Scholar
PubMed
Search for other papers by Gülay Altiparmak in
Google Scholar
PubMed
Search for other papers by Ann-Christin Illerskog in
Google Scholar
PubMed
Search for other papers by Håkan Ahlman in
Google Scholar
PubMed
Lundberg Laboratory for Cancer Research, Lundberg Laboratory for Cancer Research, Department of Biochemistry, Department of Pathology
Search for other papers by Darima Lamazhapova in
Google Scholar
PubMed
Search for other papers by Ola Nilsson in
Google Scholar
PubMed
carcinoids (7 enterochromaffin-like (ECL) cell tumours (benign) in chronic atrophic gastritis, 4 sporadic ECL cell tumours (malignant)), small intestinal (ileal) carcinoids (32 enterochromaffin cell tumours (malignant)), appendiceal carcinoids (18 classical
University of Alabama at Birmingham, Department of Surgery, Division of Surgical Oncology, Birmingham, Alabama, USA
Search for other papers by Sarah B Bateni in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Natalie G Coburn in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Search for other papers by Calvin Law in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Simron Singh in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Sten Myrehaug in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Angela Assal in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Julie Hallet in
Google Scholar
PubMed
al. 2019 ). Study cohort Patients ≥ 20 years of age diagnosed with a gastrointestinal (gastric, small intestine, colon, rectal, or appendiceal), pancreatic, or lung primary NET between January 1, 2000, and October 31, 2016, were identified in
Search for other papers by M Fraenkel in
Google Scholar
PubMed
Search for other papers by M Kim in
Google Scholar
PubMed
Endocrinology, Mount Sinai Medical Center, Department of Clinical Medicine and Surgery, Endocrinology, Erasmus MC, Department of Internal Medicine, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheeba, Israel
Search for other papers by A Faggiano in
Google Scholar
PubMed
Search for other papers by W W de Herder in
Google Scholar
PubMed
Search for other papers by G D Valk in
Google Scholar
PubMed
Search for other papers by On behalf of the Knowledge NETwork in
Google Scholar
PubMed
( Niederle et al . 2010 ; Fig. 2 A). Figure 2 Most recent incidence rates in various countries for six types of NET: (A) gastric, (B) small intestine, (C) pancreatic, (D) colon, (E) rectal, and (F) appendiceal NETs. Data for the various countries are from
Search for other papers by Ulrich-Frank Pape in
Google Scholar
PubMed
Search for other papers by Uta Berndt in
Google Scholar
PubMed
Search for other papers by Jacqueline Müller-Nordhorn in
Google Scholar
PubMed
Department of Hepatology and Gastroenterology, Institute for Social Medicine, Institute for Pathology, Department of Gastroenterology, Charité, Campus Virchow Klinikum
Search for other papers by Michael Böhmig in
Google Scholar
PubMed
Search for other papers by Stephanie Roll in
Google Scholar
PubMed
Search for other papers by Martin Koch in
Google Scholar
PubMed
Search for other papers by Stefan N Willich in
Google Scholar
PubMed
Search for other papers by Bertram Wiedenmann in
Google Scholar
PubMed
mid- (i.e. jejunal, ileal, appendiceal, caecal, ascending and right transverse colonic) and hindgut NET (i.e. left transverse colonic to rectal). This classification proved to be of only limited value because it is too inaccurate ( Klöppel et al
University College London Cancer Institute, Neuroendocrine Tumour Unit, 72 Huntley Street, London WC1E 6BT, UK
Search for other papers by A Karpathakis in
Google Scholar
PubMed
Search for other papers by H Dibra in
Google Scholar
PubMed
University College London Cancer Institute, Neuroendocrine Tumour Unit, 72 Huntley Street, London WC1E 6BT, UK
Search for other papers by C Thirlwell in
Google Scholar
PubMed
al . (2003 a ) HPM 0% appendiceal HPM NCI-H727 and HTB-119 Zhang et al . (2006) HPM 84.8% metastatic Zhang et al . (2006) HPM 60.6% non-metastatic Zhang et al . (2006) RASSF1 HPM